Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01186016 · ClinicalTrials.gov registry record · NA
Developing Genetic Education for Smoking Cessation
A NA study of Tobacco Smoking, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT01186016: Completed NA study of Tobacco Smoking, sponsored by University of Nebraska.
NCT01186016 is a NA study of Tobacco Smoking that has completed, run by University of Nebraska. The registered enrollment target is 103 participants, below the 475-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01186016, a NA study of Tobacco Smoking, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effects of an educational program about genetics and smoking on smokers' thoughts, feelings, and behaviors before and after participating in smoking cessation treatment. This includes describing participants' knowledge about genetics and smoking, their use of strategies to stop smoking, and experiences when quitting smoking. This study will determine how smokers respond to information about genetics and smoking in anticipation of using genetic information to individualize pharmacological therapy for smoking cessation. Two groups will participate in this study. The experimental group will participate in two educational sessions about genetics and smoking. The control group will participate in two educational sessions about nutrition. Both the experimental and control groups will participate in a standard, group smoking cessation program with 6 weeks of over-the-counter (OTC) transdermal nicotine replacement therapy. Assignment to either of the two groups is random. The primary specific aim is to compare the effects of the experimental group to the attention control group on smoking-related mental representations, appraisals, behaviors, and affective responses over time. The secondary aim is to explore whether personality characteristics (trait negative affectivity and curiosity) and educational level moderate the effects of the genetic educational program on smoking-related mental representations, appraisals, behaviors, and affective responses. The hypotheses of the study are as follows: 1. When compared to the attention control group, the experimental group will demonstrate: * Smoking-Related Mental Representations: * Greater knowledge of genetic contributions to smoking * Greater endorsement of genetic contributions to smoking * More positive attitudes towards NRT * Increased abstainer and decreased smoker self-schemas * Smoking-Related Appraisal: greater perceived risk for genetic predispositions to smoking * Smoki
Primary Outcome
Knowledge of genetic contributions to smoking. Name of Scale: Genetic Knowledge Test (9 items). Minimum/Maximum Scores: 0-9. Higher score means better outcome.
Conditions Studied
Interventions
- BEHAVIORAL Genetic Education Session
- BEHAVIORAL Nutrition Education Session
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2010-02-01 |
| Est. Completion | 2012-07-01 |
| Phase | NA |
What the finished NCT01186016 record still lists
NCT01186016 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 475-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Tobacco Smoking appearing as the primary indexed condition, and to 2 interventions - of which Genetic Education Session is the first listed.
NCT01186016 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT01186016 about?
NCT01186016 is a clinical study titled "Developing Genetic Education for Smoking Cessation". This study will test the effects of an educational program about genetics and smoking on smokers' thoughts, feelings, and behaviors before and after participating in smoking cessation treatment. This includes describing participants' knowledge about genetics and smoking, their use of strategies to s...
What is the current status of trial NCT01186016?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2010-02-01. Estimated completion is 2012-07-01.
What conditions does trial NCT01186016 study?
This clinical trial studies the following conditions: Tobacco Smoking.
What interventions are being tested in trial NCT01186016?
The interventions under investigation include: Genetic Education Session (BEHAVIORAL), Nutrition Education Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT01186016?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01186016 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01186016's enrollment target sits among peer trials
103 18th of 38 higher than 21 of 38 other Tobacco Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Development of a Smoking Cessation Video Series
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
RECRUITING · NA
-
Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults
RECRUITING · NA
-
CONNECT Cancer Survivors With Tobacco Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI